35 years of kids’ health research,
THE KIDS RESEARCH INSTITUTE AUSTRALIA
With
Professor Jonathan Carapetis AM,
Paediatrician & Executive Director
The Kids Research Institute Australia
RESEARCH IMPACT
Filmed in Perth, Western Australia | January 2026
The Kids Research Institute Australia is one of the largest and most successful medical research institutes in Australia. The Institute has created a blueprint that brings together community, researchers, practitioners, policy makers and funders, who share our vision to improve the health and wellbeing of children through excellence in research.
The Institute is headed by leading paediatrician and infectious diseases expert Professor Jonathan Carapetis, with Founding Director Professor Fiona Stanley now Patron.
The Kids is independent and not-for-profit. The majority of funding comes from our success in winning national and international competitive research grants. They also receive significant philanthropic support from corporate Australia and the community.
In November 2025, The Kids Research Institute Australia celebrated 35 years of bold ideas, groundbreaking research, and the people who find answers to the big questions about better health outcomes for children and families.
Since his appointment in 2012, Professor Carapetis has guided The Kids through a period of significant scientific achievement, organisational growth, and increased impact — all anchored to the Institute’s vision of ensuring happy, healthy kids.
During his tenure, Professor Carapetis oversaw major advancements in child health research, including discoveries that have influenced policy and practice, such as the recent adoption of RSV vaccinations.
He led the Institute through key milestones including the transition to new headquarters at Perth Children’s Hospital, the development of the Research Reimagined strategic plan, and the creation of a new, fresh brand.
Under Professor Carapetis’ leadership, The Kids strengthened its position as a national leader in child health research, building collaborations across Australia and internationally, supporting researchers and WA families through the COVID-19 pandemic, and driving a culture that has evolved traditional models of research, to accelerate and amplify impact, for children and their families.
Also announced in November 2025, was the news that Professor Carapetis will step down as Executive Director in July 2026, after 14 years of distinguished leadership.
Source: Adapted using The Kids Research Institute Australia news stories
You Might also like
-
Dr Meghan McIlwain
DR MEGHAN MCILWAIN, CLINICAL RESEARCH MANAGER
PRESIDENT, THE NEW ZEALAND ASSOCIATION OF CLINICAL RESEARCH,
AUCKLAND, NEW ZEALAND -
Better biomarkers for predicting the incidence of having atherosclerosis and heart attack
Assoc Prof Bursill is a vascular biologist with interests and expertise in vascular inflammation, atherosclerosis and angiogenesis. She completed her PhD at The University of Adelaide in lipid metabolism then headed to Oxford University for five years to undergo a postdoctoral post in the Departments of Cardiovascular Medicine and Pathology. Her postdoctoral time triggered her interest in the mechanisms that cause atherosclerosis and in particular the role of small inflammatory proteins called chemokines.
-
At the frontier of human cellular neuroscience research
Associate Professor Cedric Bardy is the Director of The Laboratory for Human Neurophysiology, Genetics & Stem Cells, located at SAHMRI. South Australia.
His current research uses preclinical, patient-derived cell models to test innovative therapeutic strategies, with a current focus on Parkinson’s disease, brain cancer and childhood dementia (Sanfilippo syndrome).
His work has established a platform to facilitate the discovery and validation of treatments for brain disorders. Their research is at the frontier of human cellular neuroscience research and translational applications that benefit global public health.